TGF-β/Smad signaling defects in inflammatory bowel disease: Mechanisms and possible novel therapies for chronic inflammation

Journal of Clinical Investigation

Volumn 108, Issue 4, 2001, Pages 523-526

  Fiocchi, C ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNITY; CHRONIC INFLAMMATION; CROHN DISEASE; CYTOKINE PRODUCTION; DNA BINDING; ENTERITIS; NOTE; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS;

EID: 0034891224     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI13863     Document Type: Note

References (31)

1. Inflammatory bowel disease: Etiology and pathogenesis
2. Mucosal imbalance of interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease: A novel mechanism of chronic inflammation
3. In situ expression of interleukin- 10 in noninflamed human gut and in inflammatory bowel disease
4. Expression of transforming growth factor α and β in colonic mucosa in inflammatory bowel disease
5. Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease
6. Regulation of immune responses by TGF-β
7. Transcriptional control by the TGF-β/Smad signaling system
8. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway
9. Tumor necrosis factor-α inhibits transforming growth factor-β/Smad signaling in human dermal fibroblasts via AP-1 activation
10. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
11. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
12. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β
13. Blockade of transforming growth factor β/Smad signaling in T cells by over-expression of Smad7 enhances antigen-induced airway inflammation and airway reactivity
14. TGF-β signal transduction
15. In situ response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice
16. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance
17. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4
18. A critical role of transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells
19. TGF-β production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice
20. The Iκ/NF-κB system: A key determinant of mucosal inflammation and protection
21. A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA
22. Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor κB
23. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
24. A frameshift mutation in Nod2 associated with susceptibility to Crohn's disease
25. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB
26. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
27. Recombinant interleukin 10 for the treatment of active Crohn's disease: Lessons in biologic therapy
28. Role of T-bet in commitment of Th1 cells before IL-12-dependent selection
29. CIS3/SOCS3/SS13 plays a negative regulatory role in STAT3 activation and intestinal inflammation
30. Efficacy and safety ora specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia